Hey, old dogg, thanks for theheads up. Unaware of that one. Hope everything is well with you.
Merry Christmas to questinator, flythunderbird, big, shaggy, and all the other old Ford longs. I don't think that Mulally is any longer that big a factor. Besides, if he is even considerin walking into that MSFT meatgrinder at age 68, he's not as smart as I thought.
Now we know who just paid a buck for the Jan85 put. An easy 1500% profit apparently. (The 70 is bid at a dime, which is, of course, what this opinion is worth.)
Well to remember that although this is up about 80% ytd, if you bought after July, you probably have a loss ... and a loss is a valuable thing about now.
If you bought this anytime this year, you have an unrealized short term profit of between 100 and 200%. If you sell here, you will pay a lot of taxes. In my case, between California and Federal taxes plus the medicare surcharge, about 50% of my profits. Most of us would rather continue to play with the house's money.
On the other hand, why wouldn't they wait for the reading of the RESONATE trial in January?
Remember, almost everything that happens in the first half hour of trading is a headfake. Starting to rebuild my IRA position here.
This stock has absolutely nothing to do with interest rates. It all comes down to whether or not you expect ibrutinib to be approved for CLL. Nothing else matters.
CELG off 3, GILD off 2, REGN off 4. But the rapid dump of PCYC at the open, followed by what looks to be an attempt to flatline it at 102.50 seems to me like an attempt to accumulate shares at that level. If it can't start to rebuild from here, of course, there is a danger of further erosion when some take profits in early 2014. I'm adding cautiously.
Whistling past the graveyard, I think, Holy. Herceptin is Roche's biggest moneymaker. If you only got a piece of that action, you could justify a much higher share price.
I don't know - the definitive drug for MCL, Waldenstrom's and CLL vs a potential drug for short bowel disease. (although I own some NSPS) Your "not below 100" stance suggests that some stops will get taken out there. I have some modest buy orders in under 100.
One thing we can be sure of, as the posts here demonstrate: a lot of retail investors are selling out their stakes here, and those shares are passing into other, presumably less nervous, hands.
At this point, GILD has rebounded one dollar and CELG has recovered 1.70. Let's hope that this is a precursor for PCYC.
In order to take profits at this point, you should have some losses to offset them, which, unless you are a really bad investor (long/short hedge funds?), would be hard in market which is up 24% for the year. Also, one would expect a little window dressing to lift these stocks about now.
max, these are the times that try men's souls.( My equanimity at this point is bolstered by owning a chunk of PBYI.) But in order to sell out of this position totally here, you have to believe "They know something which I don't." I don't believe that. My maxim, though, is "When something really good or really bad seems to be happening, sell half." I sold out of my underwater shares a couple of days ago in my taxable accounts, keeping my old shares. I sold all but 500 of the shares in my IRA, but am now adding back shares cautiously, which I didn't expect to do until next year.
God helps those who help themselves. Now we see the retail investors imagining all kinds of "They must know something." scenarios. After all, why aren't the professionals snapping this up here?
Probably because they know there is no immediate need to do so. However, when the trial results are released in January and the FDA rules on or before the PDUFA date in February, that will change. I don't put a lot of stock in analyst recommendations and price targets. I note that the UBS analyst, after downgrading CELG last September, when it was at 75, upgraded it on Dec 5, when it was at 165. Not too helpful. Trust your own judgment, but position yourself according to what the tape is telling you. I added a couple of hundred shares today at an average price of 102.20. I had other orders in place below 100 which didn't fill. I think that 90% of the trading in this market is phony - just passing shares back and forth; it's fascinating how a real buy order can shift the momentum. They will sell the stock to themselves at 98.80, but not to me. Not because they're afraid of my puny orders, but because when they see a 500 share order at a certain price, they worry that their buddies have stopped collaborating.
Given California tax laws, it makes sense to exercise options when they get into the money. I don't know what took him this long. There are plenty more where those came from.